NDC 72266-160-41 - Ziprasidone Mesylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72266-160
- Requested NDC
- 72266-160-41
- Package NDCs from labels
- 72266-160-01, 72266-160-10, 72266-160-41, 72266-160-42
- Manufacturer
- Fosun Pharma USA Inc.
- Effective date
- 2025-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ziprasidone Mesylate - Fosun Pharma USA Inc. | Fosun Pharma USA Inc. | 2025-03-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Ziprasidone Mesylate - Fosun Pharma USA Inc. | Fosun Pharma USA Inc. | 2025-03-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72266-160-01 | Ziprasidone Mesylate | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 6 | |
| 72266-160-10 | Ziprasidone Mesylate | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 6 | |
| 72266-160-41 | Ziprasidone Mesylate | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 3 | |
| 72266-160-42 | Ziprasidone Mesylate | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72266-160 | ZIPRASIDONE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FOSUN PHARMA USA INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250330_90f55022-8d58-4bfb-9464-9bf11395ae17.zip |
| 72266-160 | ZIPRASIDONE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FOSUN PHARMA USA INC.] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240808_b28a4f3d-0aae-050d-e053-2995a90aa4a6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72266-160-01 | EA - Each | 72266-160 | 3356fb8e-e5d7-4957-a797-e9a6fc40d0fe | 1 | 2020-08-06 |
| 72266-160-10 | EA - Each | 72266-160 | bb41c037-fef3-4994-9479-33b858c1987e | 1 | 2020-07-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 1ffd16c3-25ac-4839-9ea9-4efd32926b95 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Novadoz Pharmaceuticals LLC | 90b35a26-ab65-4c39-b97f-55c8c0e34b0b | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | 351223 3X6SAX83JZ |
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | Fosun Pharma USA Inc. | b28a4f3d-0aae-050d-e053-2995a90aa4a6 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA211908 72266-160-41 72266-160-42 72266-160 72266016041 351223 3154a481-cab5-d000-e063-6294a90a64bd b28a4f3d-0aae-050d-e053-2995a90aa4a6 3X6SAX83JZ |
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | Fosun Pharma USA Inc. | 90f55022-8d58-4bfb-9464-9bf11395ae17 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA211908 72266-160-10 72266-160-01 72266-160 351223 3154c525-bdf4-07a9-e063-6294a90a607a 90f55022-8d58-4bfb-9464-9bf11395ae17 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Gland Pharma Limited | 77a10f48-e300-465f-81b5-54be38daa4b3 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ZIPRASIDONE MESYLATE | ZIPRASIDONE MESYLATE | HF Acquisition Co LLC, DBA HealthFirst | c75971f8-9640-a6e8-e053-2995a90af654 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Dr.Reddy's Laboratories, Inc. | 3cb79985-1207-602e-2dda-a118133b4c60 | 2021-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Dr.Reddy's Laboratories, Inc. | 6fd6fc45-20c4-e223-3532-ce37aa02b71c | 2021-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.